Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(48)
•••
Post by ISAloser247on Mar 16, 2011 8:36pm
450 Views
Post# 18296266

I LIS WALKER'S E-MAIL NOT FUNCTIONING?.....

I LIS WALKER'S E-MAIL NOT FUNCTIONING?..... 

.....deal closes on January 31, 2011.  TODAY IS MARCH 16. 2011?   SIX  WEEKS? ANNOUNCEMENT MUST HAVE

BEEN    'LOST IN TRANSLATION",  much like the news from Europe, and  the Medicines Agency .   


     Just finished reading up on Dr. Raj Sherman in the Globe and Mail, WHAT IS IT WITH U of A medics?

     Is it the culture?  the crappy 'never-ending' darkness for nine months?  the fluoride in the water?     

     HONESTY,  INTEGRITY, 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities